...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pretty quiet on the Zenith front,

It's only quiet on the board kelsee. The company is quite busy.

tada

Share
New Message
Please login to post a reply